Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
756726
Reference Type
Journal Article
Title
Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy
Author(s)
Casey, BM; Dashe, JS; Spong, CY; Mcintire, DD; Leveno, KJ; Cunningham, GF
Year
2007
Is Peer Reviewed?
1
Journal
Obstetrics and Gynecology
ISSN:
0029-7844
EISSN:
1873-233X
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Location
PHILADELPHIA
Volume
109
Issue
5
Page Numbers
1129-1135
Language
English
PMID
17470594
DOI
10.1097/01.AOG.0000262054.03531.24
Web of Science Id
WOS:000246771600018
Abstract
To establish pregnancy-specific free thyroxine thresholds and to assess perinatal effects associated with isolated maternal hypothyroxinemia identified in the first half of pregnancy.
Stored serum samples from 17,298 women who previously underwent thyroid-stimulating hormone (TSH) screening in the first half of pregnancy were analyzed for free thyroxine (T(4)) concentrations and thyroid peroxidase antibodies. Women with a free T(4) below 0.86 ng/dL but a normal-range TSH were identified to have isolated maternal hypothyroxinemia. Pregnancy outcomes in these women were compared to those with a normal TSH and free T(4). Thyroid peroxidase antibody status and the relationship between TSH and free T(4) were analyzed for these women and women with subclinical hypothyroidism.
Isolated maternal hypothyroxinemia was identified in 233 women (1.3%). There were not any excessive adverse pregnancy outcomes in these women. Positive thyroid peroxidase antibody assays (greater than 50 international units/mL) were similar in normal women (4%) and those with isolated hypothyroxinemia (5%) but were greater in women with subclinical hypothyroidism (31%, P<.001). There was a negative correlation between TSH and free T(4) in normal women (r(s)=-0.19, P<.001) and those with subclinical hypothyroidism (r(s)=-0.11, P=.007). The correlation in women with isolated hypothyroxinemia was not significant.
Isolated maternal hypothyroxinemia has no adverse effects on perinatal outcome. Moreover, unlike subclinical hypothyroidism, there was a low prevalence of thyroid peroxidase antibodies and no correlation between TSH and free T(4) levels in women with hypothyroxinemia, leading us to question its biological significance.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity